Merit Medical Systems (MMSI) Expected to Announce Quarterly Earnings on Thursday

Merit Medical Systems (NASDAQ:MMSI) will likely be issuing its Q3 2025 results after the market closes on Thursday, October 30th. Analysts expect Merit Medical Systems to post earnings of $0.82 per share and revenue of $371.6940 million for the quarter. Parties may visit the the company’s upcoming Q3 2025 earningresults page for the latest details on the call scheduled for Thursday, October 30, 2025 at 5:00 PM ET.

Merit Medical Systems (NASDAQ:MMSI) last issued its earnings results on Wednesday, July 30th. The medical instruments supplier reported $1.01 EPS for the quarter, beating the consensus estimate of $0.85 by $0.16. The company had revenue of $382.46 million during the quarter, compared to analysts’ expectations of $372.47 million. Merit Medical Systems had a net margin of 8.31% and a return on equity of 15.07%. The business’s revenue for the quarter was up 13.2% compared to the same quarter last year. During the same period in the previous year, the company earned $0.92 EPS. On average, analysts expect Merit Medical Systems to post $3 EPS for the current fiscal year and $4 EPS for the next fiscal year.

Merit Medical Systems Stock Up 0.4%

Shares of NASDAQ MMSI opened at $84.52 on Thursday. The company has a 50 day simple moving average of $85.33 and a 200 day simple moving average of $89.67. Merit Medical Systems has a 1 year low of $78.12 and a 1 year high of $111.45. The firm has a market cap of $5.01 billion, a PE ratio of 42.90, a price-to-earnings-growth ratio of 2.71 and a beta of 0.58. The company has a debt-to-equity ratio of 0.49, a current ratio of 4.09 and a quick ratio of 2.66.

Analysts Set New Price Targets

A number of research analysts recently issued reports on the stock. Barrington Research reiterated an “outperform” rating and set a $103.00 target price on shares of Merit Medical Systems in a research report on Tuesday, October 7th. Canaccord Genuity Group boosted their price objective on shares of Merit Medical Systems from $103.00 to $104.00 and gave the company a “buy” rating in a research note on Thursday, October 16th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Merit Medical Systems in a report on Wednesday, October 8th. Raymond James Financial cut their target price on shares of Merit Medical Systems from $108.00 to $102.00 and set an “outperform” rating for the company in a research report on Thursday, July 31st. Finally, Wells Fargo & Company reduced their price target on shares of Merit Medical Systems from $108.00 to $100.00 and set an “overweight” rating on the stock in a research report on Thursday, July 31st. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus price target of $106.50.

Insider Buying and Selling

In other Merit Medical Systems news, Director Lynne N. Ward sold 3,000 shares of the firm’s stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $88.56, for a total value of $265,680.00. Following the transaction, the director directly owned 12,809 shares of the company’s stock, valued at approximately $1,134,365.04. This trade represents a 18.98% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 3.20% of the company’s stock.

Hedge Funds Weigh In On Merit Medical Systems

Large investors have recently made changes to their positions in the business. AQR Capital Management LLC increased its holdings in shares of Merit Medical Systems by 7.3% in the 1st quarter. AQR Capital Management LLC now owns 16,361 shares of the medical instruments supplier’s stock worth $1,730,000 after buying an additional 1,114 shares during the last quarter. Goldman Sachs Group Inc. grew its holdings in Merit Medical Systems by 16.9% in the first quarter. Goldman Sachs Group Inc. now owns 719,313 shares of the medical instruments supplier’s stock worth $76,039,000 after purchasing an additional 103,878 shares during the last quarter. EverSource Wealth Advisors LLC raised its position in shares of Merit Medical Systems by 745.9% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 922 shares of the medical instruments supplier’s stock valued at $86,000 after purchasing an additional 813 shares during the last quarter. First Trust Advisors LP lifted its stake in Merit Medical Systems by 24.8% during the 2nd quarter. First Trust Advisors LP now owns 59,215 shares of the medical instruments supplier’s stock valued at $5,535,000 after acquiring an additional 11,770 shares during the period. Finally, Cerity Partners LLC boosted its holdings in Merit Medical Systems by 9.1% during the second quarter. Cerity Partners LLC now owns 3,019 shares of the medical instruments supplier’s stock worth $282,000 after buying an additional 251 shares in the last quarter. 99.66% of the stock is currently owned by hedge funds and other institutional investors.

About Merit Medical Systems

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.